AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Nike
NKE
|
$421M |
| 2 |
Microsoft
MSFT
|
$279M |
| 3 |
Qualcomm
QCOM
|
$276M |
| 4 |
Illumina
ILMN
|
$275M |
| 5 |
International Flavors & Fragrances
IFF
|
$251M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$370M |
| 2 |
Apple
AAPL
|
$329M |
| 3 |
Biogen
BIIB
|
$316M |
| 4 |
Booking.com
BKNG
|
$216M |
| 5 |
CELG
Celgene Corp
CELG
|
$194M |
Sector Composition
| 1 | Technology | 18.47% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 15.34% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Dianthus Therapeutics
DNTH
$853M
| $236K | ﹤0.01% |
975
+37
| +4% | +$8.96K |
|
2852
Graham Corp
GHM
$524M
| $236K | ﹤0.01% |
10,800
-300
| -3% | -$6.56K |
|
|
LTS
2853
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $236K | ﹤0.01% |
67,900
-35,400
| -34% | -$123K |
|
|
TACO
2854
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $236K | ﹤0.01% |
29,800
-4,600
| -13% | -$36.4K |
|
2855
Primis Financial Corp
FRST
$275M
| $235K | ﹤0.01% |
14,400
-1,600
| -10% | -$26.1K |
|
2856
Seres Therapeutics
MCRB
$169M
| $235K | ﹤0.01% |
3,400
| – | – |
|
|
TAST
2857
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $235K | ﹤0.01% |
33,400
-11,300
| -25% | -$79.5K |
|
2858
PAR Technology
PAR
$1.96B
| $234K | ﹤0.01% |
7,600
-5,400
| -42% | -$166K |
|
2859
Olympic Steel
ZEUS
$379M
| $234K | ﹤0.01% |
13,050
-1,700
| -12% | -$30.5K |
|
|
GCAP
2860
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $233K | ﹤0.01% |
59,000
-1,700
| -3% | -$6.71K |
|
2861
KLX Energy Services
KLXE
$33.7M
| $232K | ﹤0.01% |
7,206
-2,090
| -22% | -$67.3K |
|
2862
Ameresco
AMRC
$1.37B
| $231K | ﹤0.01% |
13,221
-2,679
| -17% | -$46.8K |
|
2863
Costamare
CMRE
$1.45B
| $231K | ﹤0.01% |
24,200
-26,800
| -53% | -$256K |
|
|
CBIO
2864
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $231K | ﹤0.01% |
436
| – | – |
|
|
PFBI
2865
DELISTED
Premier Financial Bancorp
PFBI
| $231K | ﹤0.01% |
12,712
-300
| -2% | -$5.45K |
|
|
SRGA
2866
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $230K | ﹤0.01% |
2,798
| – | – |
|
2867
B2Gold
BTG
$5.52B
| $229K | ﹤0.01% |
57,000
| – | – |
|
2868
Ocular Therapeutix
OCUL
$2.37B
| $229K | ﹤0.01% |
57,900
| – | – |
|
|
CBAY
2869
DELISTED
Cymabay Therapeutics
CBAY
| $229K | ﹤0.01% |
116,800
| – | – |
|
2870
Blue Bird Corp
BLBD
$1.87B
| $227K | ﹤0.01% |
9,900
-3,900
| -28% | -$89.4K |
|
2871
SIGA Technologies
SIGA
$603M
| $227K | ﹤0.01% |
47,500
+1,500
| +3% | +$7.17K |
|
|
DSPG
2872
DELISTED
DSP Group Inc
DSPG
| $227K | ﹤0.01% |
14,450
-3,000
| -17% | -$47.1K |
|
2873
Transmedics
TMDX
$3.55B
| $226K | ﹤0.01% |
11,900
+700
| +6% | +$13.3K |
|
2874
Mistras Group
MG
$307M
| $225K | ﹤0.01% |
15,740
-2,300
| -13% | -$32.9K |
|
2875
Solid Biosciences
SLDB
$428M
| $225K | ﹤0.01% |
3,373
| – | – |
|